On the basis of results from targeted LC-MS/MS and analytical performance development, three peptides corresponding to PF4, ITIH4, and APOE were measured in 100 early-stage CRC, 106 late-stage CRC, and 80 HC samples (Table 1). This evidence concerns the gene PF4 and colorectal carcinoma.